Dr. Art Rastinehad Earns 12th Consecutive Castle Connolly Top Doctor Recognition for Urology

Art Rastinehad, DO, a distinguished urology expert, has been named a 2026 Castle Connolly Top Doctor for his twelfth consecutive year. This elite recognition places Dr. Rastinehad among the nation's top 7 percent of licensed physicians, selected through rigorous peer nomination and physician-led research. He serves as Professor of Urology and Radiology, Vice Chair of Urology at Northwell's Lenox Hill Hospital, and Northwell Health System Director for Prostate Cancer, specializing in precision diagnosis, image-guided treatment, and interventional urology.

Dr. Rastinehad's patient-centered philosophy empowers men to make informed decisions about prostate health. He states, "Being recognized as a Castle Connolly Top Doctor is meaningful because it reflects the trust patients and peers place in our work." His practice champions "precision prostate care," assessing individual histories, MRI findings, and personal goals to tailor optimal treatment paths, avoiding generic approaches for enlarged prostate and localized prostate cancer.

A pioneer in image-guided prostate care, Dr. Rastinehad's team validated MR/US fusion biopsy for prostate cancer detection. As the first dual fellowship-trained urologic oncologist and interventional radiologist, his unique expertise integrates cancer surgery, advanced imaging, and minimally invasive therapies. Key achievements include publishing the first prostate artery embolization series in 2006 and spearheading UroNav/Philips MR/US fusion technology, advancing prostate diagnosis and treatment.